Form 4: BILL Awards 87,600 RSUs to CEO Rene Lacerte; 3-Year Vesting
Rhea-AI Filing Summary
Rene A. Lacerte, CEO and director of BILL Holdings, Inc. (BILL), was awarded 87,600 restricted stock units (RSUs) on 09/15/2025. Each RSU represents a contingent right to receive one share of common stock and the award is held directly by the reporting person. The RSUs vest in 12 equal quarterly installments over three years beginning November 28, 2025, subject to the reporting persons continued service on each vesting date. The reported grant shows 87,600 shares beneficially owned following the transaction and a reported price of $0 per RSU. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/17/2025.
Positive
- CEO awarded 87,600 RSUs as disclosed on 09/15/2025
- Vesting schedule clearly defined: 12 equal quarterly installments over three years beginning 11/28/2025
- Each RSU converts to one share (explicitly stated in the explanation)
Negative
- Grant will result in issuance of up to 87,600 shares upon vesting, which may dilute existing shareholders
- No performance conditions disclosed in the filing, as the RSUs are time-based only
Insights
TL;DR: Board-level executive awarded time-based equity; standard vesting schedule aligns compensation with continued service.
The filing documents a time-based equity award to the CEO and director consisting of 87,600 RSUs that vest in 12 equal quarterly installments over three years starting November 28, 2025. This is a routine form of executive compensation intended to deliver shares over a multi-year period. The award is reported as directly owned and the RSUs are described as contingent rights to receive one share each. No accelerated vesting, performance conditions, or cash consideration are disclosed in the Form 4.
TL;DR: Material grant size disclosed; vesting schedule and direct ownership are clearly stated without performance conditions.
The disclosure specifies a single grant of 87,600 RSUs to Rene A. Lacerte on 09/15/2025 with vesting in 12 equal quarterly installments over three years beginning 11/28/2025. Each RSU converts to one share upon settlement as described. The grant price is reported as $0, indicating an equity award rather than a purchase. The Form 4 does not describe any performance metrics, accelerated vesting events, or related-party transfers. For investors, the filing is a clear, standard compensation disclosure without additional contingencies disclosed.